|
US5411984A
(en)
|
1992-10-16 |
1995-05-02 |
Virginia Tech Intellectual Properties, Inc. |
Water soluble analogs and prodrugs of taxol
|
|
GB2278843A
(en)
*
|
1993-06-07 |
1994-12-14 |
British Tech Group |
Anti-cancer compounds
|
|
US5534499A
(en)
|
1994-05-19 |
1996-07-09 |
The University Of British Columbia |
Lipophilic drug derivatives for use in liposomes
|
|
AU735205B2
(en)
|
1997-05-16 |
2001-07-05 |
Commonwealth Scientific And Industrial Research Organisation |
Vaccine and assay
|
|
US5981564A
(en)
*
|
1998-07-01 |
1999-11-09 |
Universite Laval |
Water-soluble derivatives of paclitaxel, method for producing same and uses thereof
|
|
AU2002953095A0
(en)
*
|
2002-11-29 |
2002-12-19 |
Biota Scientific Management Pty Ltd |
Novel chemical compounds and their use
|
|
NO319551B1
(no)
|
2003-07-04 |
2005-08-29 |
Thia Medica As |
Proteinmateriale fra enkeltceller
|
|
GB0321613D0
(en)
|
2003-09-15 |
2003-10-15 |
Drug Discovery Lab As |
Compounds
|
|
EP1670515A2
(en)
|
2003-09-19 |
2006-06-21 |
Novo Nordisk A/S |
Albumin-binding derivatives of therapeutic peptides
|
|
RU2340616C2
(ru)
*
|
2003-10-29 |
2008-12-10 |
Сонус Фармасьютикалз, Инк. |
Токоферол-модифицированные терапевтические лекарственные соединения
|
|
GB0412181D0
(en)
*
|
2004-06-01 |
2004-06-30 |
Celltech R&D Ltd |
Biological products
|
|
EP1804838A2
(en)
*
|
2004-09-15 |
2007-07-11 |
Drug Discovery Laboratory AS |
Drug conjugates of long chain fatty acid or ester moieties as protein binding prodrugs
|
|
ES2484796T3
(es)
|
2005-03-18 |
2014-08-12 |
Novo Nordisk A/S |
Compuestos de GLP-1 extendidos
|
|
WO2007075825A2
(en)
*
|
2005-12-20 |
2007-07-05 |
Sonus Pharmaceuticals, Inc. |
Lipophilic anticancer drug compounds
|
|
BRPI0907754A2
(pt)
|
2008-02-08 |
2015-07-21 |
Aileron Therapeutics Inc |
Macrociclos peptidomiméticos terapêuticos
|
|
CA2721153C
(en)
*
|
2008-04-10 |
2018-10-02 |
Abraxis Bioscience, Llc |
Compositions of hydrophobic taxane derivatives and uses thereof
|
|
WO2010107487A2
(en)
|
2009-03-18 |
2010-09-23 |
Wu Nian |
Lipid-drug conjugates for drug delivery
|
|
CA2756397A1
(en)
|
2009-04-02 |
2010-10-07 |
Shire Llc |
Novel dicarboxylic acid linked amino acid and peptide prodrugs of opioids and uses thereof
|
|
WO2011085000A2
(en)
|
2010-01-06 |
2011-07-14 |
The University Of North Carolina At Chapel Hill |
Fatty acid derivatives and analogs of drugs
|
|
RU2012134974A
(ru)
|
2010-01-22 |
2014-02-27 |
Ново Нордиск Хелс Кеа Аг |
Стабилизированное соединение гормона роста
|
|
PL2525834T3
(pl)
|
2010-01-22 |
2020-10-19 |
Novo Nordisk Health Care Ag |
Hormony wzrostu o przedłużonej skuteczności in-vivo
|
|
ES2582590T3
(es)
|
2010-02-16 |
2016-09-13 |
Novo Nordisk A/S |
Método de purificación
|
|
CN103002891B
(zh)
*
|
2010-05-10 |
2016-10-26 |
加利福尼亚大学董事会 |
比例计量型组合药物递送
|
|
EP2392324A1
(en)
*
|
2010-06-01 |
2011-12-07 |
Societe De Coordination De Recherches Therapeutiques |
Rhenium complexes and their pharmaceutical use
|
|
BR112013007442A2
(pt)
|
2010-09-28 |
2019-09-24 |
Amylin Pharmaceuticals Llc |
polipeptídeos construídos tendo duração de ação realçada
|
|
MX349054B
(es)
|
2010-09-28 |
2017-07-07 |
Aegerion Pharmaceuticals Inc |
Leptinas altamente solubles.
|
|
WO2012048204A2
(en)
*
|
2010-10-08 |
2012-04-12 |
Virginia Commonwealth University |
Prodrugs utilizing a transporter directed uptake mechanism
|
|
EP2723452A2
(en)
|
2011-06-22 |
2014-04-30 |
Vyome Biosciences Pvt Ltd |
Conjugate-based antifungal and antibacterial prodrugs
|
|
JP6006309B2
(ja)
|
2011-07-08 |
2016-10-12 |
アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc |
作用持続期間が増大し、免疫原性が減少した操作されたポリペプチド
|
|
DK2729160T3
(da)
|
2011-07-08 |
2019-07-01 |
Aegerion Pharmaceuticals Inc |
Manipulerede polypeptider, der har forbedret virkningstid og reduceret immunogenicitet
|
|
KR101435261B1
(ko)
*
|
2012-07-23 |
2014-09-02 |
아주대학교산학협력단 |
항암제-링커-알부민 결합체, 이의 제조방법 및 상기 결합체를 포함하는 약물 전달용 조성물
|
|
WO2014078895A1
(en)
*
|
2012-11-21 |
2014-05-30 |
The University Of Sydney |
Omega-3 analogues
|
|
WO2014121033A1
(en)
*
|
2013-02-04 |
2014-08-07 |
Fl Therapeutics Llc |
Soluble complexes of drug analogs and albumin
|
|
US20160115192A1
(en)
*
|
2013-06-10 |
2016-04-28 |
Cedars-Sinai Medical Center |
Antioxidant, anti-inflammatory and anticancer derivatives of triptolide and nanospheres thereof
|
|
WO2015081891A1
(en)
|
2013-12-06 |
2015-06-11 |
Baikang (Suzhou) Co., Ltd |
Bioreversable promoieties for nitrogen-containing and hydroxyl-containing drugs
|
|
CN107708702A
(zh)
*
|
2014-11-17 |
2018-02-16 |
塞勒克塔生物科学有限公司 |
磷脂醚类似物作为靶向癌症的药物载体
|
|
CN104478813A
(zh)
*
|
2014-12-20 |
2015-04-01 |
苏州博源医疗科技有限公司 |
5-氟尿嘧啶衍生物、5-氟尿嘧啶免疫原及其抗体与5-氟尿嘧啶检测试剂盒
|
|
US10286079B2
(en)
*
|
2015-09-22 |
2019-05-14 |
The Regents Of The University Of California |
Modified cytotoxins and their therapeutic use
|
|
MY193776A
(en)
*
|
2015-09-22 |
2022-10-27 |
Univ California |
Modified cytotoxins and their therapeutics use
|
|
US20200048198A1
(en)
*
|
2017-03-22 |
2020-02-13 |
The Regents Of The University Of California |
Modified histone deacetylase inhibitors and uses thereof
|
|
US20210137874A1
(en)
*
|
2017-03-22 |
2021-05-13 |
The Regents Of The University Of California |
Modified platinum compounds and therapeutic uses thereof
|
|
US20210137957A1
(en)
*
|
2017-03-22 |
2021-05-13 |
The Regents Of The University Of California |
Modified anthracycline compounds and their therapeutic use
|
|
AU2018258345A1
(en)
*
|
2017-04-27 |
2019-10-17 |
The Regents Of The University Of California |
Modified mri contrast agents and uses thereof
|